Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | cMet RNA CAR T cells |
| Synonyms | |
| Therapy Description |
cMet RNA CAR T cells are autologous T-cells transfected with RNA that codes for a chimeric antigen receptor comprised of a portion of anti-Met and CD3-zeta chain linked to CD-137, which targets T-cells to c-MET expressing tumor cells, resulting in selective toxicity (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| cMet RNA CAR T cells | cMet CAR-mRNA electroporated autologous T lymphocytes | MET Immune Cell Therapy 1 MET Inhibitor 59 | cMet RNA CAR T cells are autologous T-cells transfected with RNA that codes for a chimeric antigen receptor comprised of a portion of anti-Met and CD3-zeta chain linked to CD-137, which targets T-cells to c-MET expressing tumor cells, resulting in selective toxicity (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|